Higher BMI Linked to Heart Damage during Chemotherapy in Breast Cancer patients
Written By : Isra Zaman
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-09-05 04:00 GMT | Update On 2023-09-05 10:07 GMT
A recent study in the North-East region of Colombia found 11.94% of patients with a high BMI being treated for breast cancer at a regional center experienced heart damage, or cardiotoxicity, during chemotherapy.
An anonymized database of breast cancer patients who started chemotherapy with doxorubicin or trastuzumab between January and December 2021 was used for the study. The analysis only included patients who had a baseline echocardiogram and at least one follow-up echocardiogram. The database also recorded sociodemographic, oncological, cardiovascular and echocardiographic variables.
Ref: ACC
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd